2021
DOI: 10.21037/qims-20-875
|View full text |Cite
|
Sign up to set email alerts
|

Role of 18F-FDG PET/CT in the differential diagnosis of primary benign and malignant unilateral adrenal tumors

Abstract: Background: This retrospective study was performed to estimate the clinical role of whole-body positron emission tomography/computed tomography (PET/CT) using 2-[ 18 F] fluoro-2-deoxy-D-glucose (FDG) in the differential diagnosis of primary benign and malignant unilateral adrenal tumors. Methods: A total of 64 patients (31 male, 33 female; age range: 3-76 years, mean: 48.5) with a confirmed unilateral adrenal tumor underwent 18 F-FDG PET/CT examination for diagnosis and staging. The whole-body 18 F-FDG PET/CT … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 12 publications
0
4
0
2
Order By: Relevance
“…Ma et al. displayed that SUVmax of malignant lesions (10.0 ± 5.8) was higher than that of benign lesions (5.4 ± 5.3, P < 0.05), and as a result of this finding, the SUV-ROC method has a sensitivity of 81.25% and specificity of 72.91% ( 23 ). Another study by Perry et al.…”
Section: Discussionmentioning
confidence: 99%
“…Ma et al. displayed that SUVmax of malignant lesions (10.0 ± 5.8) was higher than that of benign lesions (5.4 ± 5.3, P < 0.05), and as a result of this finding, the SUV-ROC method has a sensitivity of 81.25% and specificity of 72.91% ( 23 ). Another study by Perry et al.…”
Section: Discussionmentioning
confidence: 99%
“…ПЭТ/КТ с 18-фтор-дезоксиглюкозой ( 18 F-ФДГ) основан на разнице интенсивности метаболизма глюкозы между опухолевыми клетками и интактными тканями [52]. Изначально 18 F-ФДГ ПЭТ/КТ использовалась для дифференциальной диагностики добро-и злокачественных образований различной локализации (с уровнем чувствительности 92-100%, специфичности 80-100%) [53][54][55]. 18 F-ФДГ ПЭТ/КТ чаще всего используется в онкологии для визуализации, стадирования и мониторинга терапии.…”
Section: F-fdg (Fluorodeoxyglucose)unclassified
“…Было продемонстрировано, что гормонально активные образования надпочечников характеризуются высоким захватом 18 F-ФДГ в сравнении с неактивными [55,[62][63][64], что открывает новые возможности РФП в оценке статуса как опухолей коры надпочечников, так и образований мозгового слоя [64][65][66]. На данный момент перед специалистами стоит задача в определении единой точки отсечения уровня захвата (SUVmax, Adrenal/Liver SUVmax) для дифференциальной диагностики между активными и неактивными опухолями коры надпочечников, и подобной точки для различия доброкачественных и злокачественных ФХ [67].…”
Section: F-fdg (Fluorodeoxyglucose)unclassified
“…As an accurate noninvasive imaging method, positron emission tomography/computed tomography (PET/CT) with 2-[ 18 F]-fluoro-2-deoxy-D-glucose ( 18 F-FDG) has received widespread clinical recognition for the diagnosis and evaluation of pulmonary lesions ( 2 - 4 ). In clinical practice, a PET/CT examination is currently mainly performed as static imaging, and the data are evaluated in units of standardized uptake value (SUV) ( 5 , 6 ). However, due to factors such as plasma glucose level, body composition, lesion type, and scan time, the semiquantitative indicator SUV not only always has great variability but also low specificity for malignant lesions ( 7 , 8 ).…”
Section: Introductionmentioning
confidence: 99%